Do you have the same question? Follow this Question
May 13, 2026 - 08:35 AM
We’ve provided several answers to questions related to Voxzogo (Vosoritide) , see some other helpful Q&A related to this product.
Question: Can this medication be used in children under 5 years of age?
Answer: The safety and effectiveness in children under 5 years of age have not been established. Using medications only in approved age groups ensures patient safety and the likelihood of therapeutic benefit.
Question: What is the bioavailability of this medication?
Answer: The bioavailability is approximately 75% when administered subcutaneously. Bioavailability indicates the proportion of the drug that enters circulation and is available to have an effect, ensuring reliable therapeutic outcomes.
Question: What is the main ingredient in this medication?
Answer: The main ingredient is vosoritide, which is a C-type natriuretic peptide (CNP) analog. CNP analogs mimic the action of natural peptides in the body to regulate bone growth, providing value for individuals with achondroplasia by promoting healthier skeletal development.
